Applied Total Current Assets vs Total Liab Analysis
APDN Stock | USD 0.60 0.01 1.64% |
Applied DNA financial indicator trend analysis is way more than just evaluating Applied DNA Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Applied DNA Sciences is a good investment. Please check the relationship between Applied DNA Total Current Assets and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Total Current Assets vs Total Liab
Total Current Assets vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Applied DNA Sciences Total Current Assets account and Total Liab. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Applied DNA's Total Current Assets and Total Liab is 0.47. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Total Liab in the same time period over historical financial statements of Applied DNA Sciences, assuming nothing else is changed. The correlation between historical values of Applied DNA's Total Current Assets and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of Applied DNA Sciences are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Total Current Assets i.e., Applied DNA's Total Current Assets and Total Liab go up and down completely randomly.
Correlation Coefficient | 0.47 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from Applied DNA's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Applied DNA Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. As of the 2nd of June 2024, Selling General Administrative is likely to drop to about 10 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 10.3 M
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 18.2M | 13.4M | 15.4M | 16.1M | Research Development | 3.9M | 3.7M | 4.3M | 4.5M |
Applied DNA fundamental ratios Correlations
Click cells to compare fundamentals
Applied DNA Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Applied DNA fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Current Liabilities | 4.3M | 3.3M | 4.2M | 2.8M | 3.3M | 3.9M | |
Total Stockholder Equity | 5.7M | 11.1M | 12.9M | 5.0M | 5.7M | 6.0M | |
Retained Earnings | (269.8M) | (284.1M) | (292.5M) | (302.4M) | (272.2M) | (258.6M) | |
Accounts Payable | 1.3M | 2.0M | 1.7M | 1.1M | 1.2M | 921.1K | |
Common Stock Shares Outstanding | 196.0K | 345.9K | 448.4K | 653.8K | 751.8K | 789.4K | |
Non Current Liabilities Total | 1.4M | 31.5K | 5.2M | 5.9M | 6.8M | 7.2M | |
Other Stockholder Equity | 275.5M | 295.2M | 305.4M | 307.4M | 353.5M | 371.2M | |
Total Liab | 5.6M | 3.3M | 9.4M | 8.8M | 10.1M | 10.6M | |
Common Stock | 5.1K | 7.5K | 12.9K | 13.7K | 12.3K | 11.7K | |
Other Current Liab | 676.4K | 980.9K | 1.9M | 1.2M | 1.1M | 1.1M | |
Total Assets | 11.3M | 14.4M | 22.3M | 13.7M | 15.7M | 16.5M | |
Net Debt | (5.4M) | (6.6M) | (15.2M) | (5.9M) | (5.3M) | (5.1M) | |
Cash | 7.8M | 6.6M | 15.2M | 7.2M | 8.2M | 8.6M | |
Cash And Short Term Investments | 7.8M | 6.6M | 15.2M | 7.2M | 8.2M | 8.6M | |
Liabilities And Stockholders Equity | 11.3M | 14.4M | 22.3M | 13.7M | 15.7M | 16.5M | |
Total Current Assets | 9.1M | 11.3M | 19.9M | 8.1M | 9.3M | 5.0M | |
Non Current Assets Total | 2.3M | 3.1M | 2.3M | 5.5M | 6.4M | 6.7M | |
Intangible Assets | 864.2K | 734.8K | 605.3K | 2.7M | 2.4M | 2.6M | |
Property Plant And Equipment Net | 1.3M | 3.0M | 2.2M | 2.1M | 2.4M | 2.5M | |
Current Deferred Revenue | 511.0K | 281K | 563.6K | 76.4K | 68.8K | 65.4K | |
Non Currrent Assets Other | 95.1K | 95.0K | 99.0K | 750K | 862.5K | 905.6K | |
Property Plant And Equipment Gross | 1.3M | 3.8M | 4.3M | 5.5M | 6.3M | 6.6M | |
Net Receivables | 194.3K | 2.8M | 3.1M | 255.5K | 293.8K | 279.1K | |
Other Current Assets | 599.3K | 568.9K | 1.1M | 389.2K | 447.6K | 373.6K | |
Net Tangible Assets | (1.9M) | 4.8M | 11.1M | 12.9M | 14.8M | 15.6M | |
Property Plant Equipment | 226.2K | 1.3M | 3.0M | 2.2M | 2.6M | 2.7M | |
Other Assets | 172.0K | 95.1K | 95.0K | 99.0K | 89.1K | 84.6K | |
Inventory | 497.4K | 1.4M | 602.2K | 330.0K | 379.5K | 347.2K | |
Other Liab | 622.0K | 848.3K | 31.5K | 5.2M | 5.9M | 6.2M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Applied DNA Sciences information on this page should be used as a complementary analysis to other Applied DNA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Applied Stock analysis
When running Applied DNA's price analysis, check to measure Applied DNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied DNA is operating at the current time. Most of Applied DNA's value examination focuses on studying past and present price action to predict the probability of Applied DNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied DNA's price. Additionally, you may evaluate how the addition of Applied DNA to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Stocks Directory Find actively traded stocks across global markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Applied DNA's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (17.63) | Revenue Per Share 7.666 | Quarterly Revenue Growth (0.79) | Return On Assets (0.64) | Return On Equity (2.52) |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.